Technology driven

Technology driven biopharma player with differentiated portfolio and global presence

12th largest in India

Ranked one of the fastest growing and 12th largest pharma player in India
(* as per AIOCD-AWACS June 2024)

Committed to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives

We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

icons
12th Largest Pharma Company in India,
In terms of Domestic Sales for MAT June 2024
icons
10,852 Employees
As of September 30, 2023
icons
70+ Countries with presence

Focus Areas

Established presence in key therapeutic areas

Gynaecology
Cardiology
Anti-infective
Vitamins, minerals and nutrients
Diabetes
Anti-Retro Virals
Biologics
mRNA vaccine

Research and Development

We are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics. Our in-house research and development capabilities are the cornerstone of our operations and continued growth.

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more

Newsroom

December 4, 2024

Enter News ContentCompanies offer "holistic support" to candidates under PM Internship scheme: MCA

November 9, 2024

Emcure Pharmaceuticals Teams up with MS Dhoni to Bat for Stroke Awareness Across the Country Health and Wellbeing

November 7, 2024

Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%

October 28, 2024

Emcure Pharma sets up subsidiary Emcutix Biopharmaceuticals focused on dermatology

October 3, 2024

Emcure Pharma signs pact with Gilead for manufacturing, supply of HIV drug lenacapavir globally

September 30, 2024

Emcure Pharma's "ACE YOUR HEART" awareness campaign enters Asia Book of Records on World Heart Day

Placeholder Image

Life at Emcure

We aim to enhance and sustain the performance of our employees by continuously developing both functional and behavioral competencies across businesses.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.

explore